PAREXEL International (PRXL) & Editas Medicine (EDIT) Financial Comparison – StockNewsTimes
StockNewsTimes |
PAREXEL International (PRXL) & Editas Medicine (EDIT) Financial Comparison
StockNewsTimes It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … |
